Abstract:AIM:To study the effects of perioperative administration of cimetidine (CIM) on peripheral blood lymphocytes, natural killer (NK) cells and tumor infiltrating lymphocytes (TIL) in patients with gastrointestinal (GI) cancer.METHODS:Forty-nine GI cancer patients were randomized into treatment group, who took CIM in perioperative period, and control group, who did not take the drug. The treatment was initiated 7 days before operation and continued for 10 days after surgery. At baseline examination before operation, on the 2nd and 10th postoperative days, total T lymphocytes, T helper cells, T suppressor cells, and NK cells in peripheral blood were measured respectively by immunocytochemical method using mouse-anti human CD(3), CD(4), CD(8) and CD(57) monoclonal antibodies. Blood samples from 20 healthy volunteers were treated in the same way as normal controls. Surgical specimens were examined during routine histopathological evaluation for the presence of TIL in tumor margin. Immunohistochemical study was performed to measure the proportion of T and B lymphocytes in TIL population. T and B lymphocytes were detected respectively using mouse-anti-human CD(3) and CD(20) monoclonal antibodies.RESULTS:In comparison with normal controls, both the treatment and control groups had decreased T cells, T helper cells and NK cells at baseline. In control group, total T cells, T helper cells and NK cells declined continuously with the disease progression and the decrease became more obvious after operation. From baseline to the 2nd postoperative day, the proportion of total T cells, T helper cells, and NK cells went down from 60.5+/-4.6% to 56.2+/-3.8%, 33.4+/-3.7% to 28.1+/-3.4%, and 15.0+/-2.8% to 14.2+/-2.2%, respectively. On the other hand, there were significant improvements in these parameters after CIM treatment. On the 10th postoperative day, the treatment group had significantly higher percentages of total T cells, T helper cells and NK cells than control group. Moreover, CIM treatment also boosted TIL response, as was reflected by findings that 68% (17/25) of the patients in treatment group had significant TIL responses and only 25% (6/24) of the cases had discernible TIL responses (P<0.01).CONCLUSION:Perioperative application of CIM to GI cancer patients could help restore the diminished cellular immunity induced by tumor burden and surgical maneuver. The drug could also boost TIL responses to tumor. These effects suggest that the drug be used as an immunomodulator for GI cancer patients.

Effects of cimetidine on T lymphocyte subsets in perioperative gastrointestinal cancer patients

Perioperative Cimetidine Administration Promotes Peripheral Blood Lymphocytes and Tumor Infiltrating Lymphocytes in Patients with Gastrointestinal Cancer: Results of a Randomized Controlled Clinical Trial.

Cimetidine Enhances Local Lymphocytes Response to Gastrointestinal Cancer:Results of a Clinical Trail

Short Term Therapeutic Effect on Treatment of Postoperational Large Intestine Carcinoma by Fupiyiwei Decoction Combined with Chemotherapy and It's Effect on Immune Fuction

Perioperative cimetidine administration improves systematic immune response and tumor infiltrating lymphocytes in patients with colorectal cancer

Effects of perioperative cimetidine administration on natural killer cells in patients with gastrointestinal cancer

Perioperative Cimetidine Administration Enhances Tumor Infiltration Lymphocytes and HLA-DR Expression in Colorectal Cancer

Effects of Perioperative Cimetidine Administration on Tumor Cell Nuclear Morphometry and DNA Content in Patients with Gastrointestinal Cancer

Effects of surgery on immune function in patients with gastrointestinal cancer

Expression of HLA-DR antigen on the peripheral blood lymphocytes in gastric cancer patients and effects of cimetidine

Effects of Cimetidine on the Erythrocyte Immune Function and Interleukin- 2 in Patients with Obstructive Jaundice after Bililary Drainage

Protective effect of cimetidine on immune function of mice irradiated by gamma-rays

Preoperative Enteral Immunonutrition Improves Postoperative Outcome in Patients with Gastrointestinal Cancer

Effect of Neoadjuvant Chemotherapy on the Tumor Cell Proliferation and Peripheral Blood T Lymphocyte Subsets of the Ⅲ/Ⅳ Interim Low Rectal Carcinoma

Protective Effect of Cimetidine on Intestinal Immune System of Low Dose-Irradiated Mice

Effect of Chemotherapy on Immunologic Function in Patients with Gastric Cancer

Levels of Peripheral Blood T Subgroups and Serum Sil-2 R in Perioperation Period in Patients with Gastric Cancer

The effects of perioperative enteral immunonutrition in patients with gastric cancer

[Influence of Intravenous Chemotherapy on Cellular Immunity in Patients with Advanced Digestive Tract Cancer].

Cimetidine repurposed as a potential immunomodulatory agent against colorectal carcinoma: A systematic review

The Effect of Immunotherapy on the Gut Microbiota, Intestinal Barrier, and Immune Function in Patients with Gastric Cancer